- Home
- IGC vs LSTA Comparison
IGC vs LSTA Comparison
Compare IGC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IGC | LSTA |
|---|---|---|
| Founded | 2005 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0M | 28.9M |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IGC | LSTA |
|---|---|---|
| Price | $0.28 | $3.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.25 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 565.0K | 96.8K |
| Earning Date | 03-19-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | 20.42 |
| EPS | ★ N/A | N/A |
| Revenue | $1,271,000.00 | ★ $35,283,868.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 56.90 |
| 52 Week Low | $0.24 | $1.81 |
| 52 Week High | $0.50 | $5.07 |
Technical Indicators
Market Signals| Indicator | IGC | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 53.53 |
| Support Level | $0.28 | $3.06 |
| Resistance Level | $0.31 | $3.67 |
| Average True Range (ATR) | 0.01 | 0.18 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 8.12 | 44.68 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.